Clinical Trial Update: UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 study of UCN-01 with prednisone in adults with lymphoma or solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• PREDNISONE (Prednisone)
• UCN-01 (7-hydroxystaurosporine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: COMPLETED